We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI-Based Method Could Replace Chemical Staining of Histopathological Tissue Samples

By LabMedica International staff writers
Posted on 17 Apr 2023

For over a century, chemical staining has been a foundational technique in the study of histopathology, particularly in areas like cancer diagnostics. More...

One major drawback of chemical staining, however, is its irreversible nature, which often restricts the sample's use in other tests or experiments. To address this limitation, researchers have developed an artificial intelligence (AI)-based approach to virtually stain histopathological tissue samples, potentially replacing the need for chemical staining.

A study led by researchers from the University of Eastern Finland (Kuopio, Finland) has resulted in the development of an AI method that generates computational images closely resembling those obtained through actual chemical staining. These virtually stained images can then be examined for tissue morphology. The virtual staining technique not only reduces the chemical load and manual labor required for sample processing but also allows the tissue to be used for other purposes beyond staining. A key advantage of the proposed method is that it only requires a standard light microscope and an appropriate computer, with no need for specialized hardware or infrastructure.

The rapid advancement of deep neural networks, which learn from vast amounts of data, has revolutionized biomedical image analysis. These methods are not only suitable for traditional image analysis tasks, such as interpretation, but also excel in image-to-image transformations. Virtual staining exemplifies this type of task and was effectively demonstrated by the research team.

“The results are very widely applicable. There are plenty of topics for follow-up research, and the computational methods can still be improved. However, we can already envision several application areas where virtual staining can have a major impact in histopathology,” says Associate Professor Pekka Ruusuvuori from the University of Turku, who led the computational part of the study.

“Deep neural networks are capable of performing at a level we were not able to imagine a while ago. Artificial intelligence-based virtual staining can have a major impact towards more efficient sample processing in histopathology,” said Doctoral Researcher Umair Khan from the University of Turku who was the lead developer.

Related Links:
University of Eastern Finland 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.